ОСОБЕННОСТИ ИММУННОГО ВОСПАЛЕНИЯ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ И БРОНХИАЛЬНОЙ АСТМОЙ

Background: To improve differential diagnosis of chronic obstructive pulmonary disease (COPD) and bronchial asthma (BA), identification of new biological markers is needed. Aim: To differentiate between COPD and BA using modern immunological methods. Results: Conducted a comparative study of surface markers of peripheral blood lymphocytes in peripheral blood lymphocytes, expresarse antigens CD3, CD4, CD8, CD16, CD20, CD23, CD25, CD54, CD71, CD72, HLA-DR, CD95 and membrane immunoglobulins mIgM and mIgG in patients with chronic obstructive pulmonary disease (COPD) and atopic asthma in the acute stage. Shows significant differences in the changes of surface phenotype of lymphocytes in the studied diseases. In addition, in COPD, there is a considerable increase in the content of cytotoxic lymphocytes (CD 4+, CD8+ and 34 %, CD16 + NK cells by more than 33 % of normal ) in the blood is not dependent on stage of the disease. It is suggested that the high cytotoxic potential of the immune system is the cause of more damage to the lung tissue, causing the development of pulmonary
fibrosis, emphysema and systemic damage in COPD. In patients with ABA during remission of the activity of cytotoxic cells is reduced, and observed the predominance of the processes of activation of apoptosis of lymphocytes (CD95) on their willingness to differentiation and acquisition of late differentiation antigen (HLA-DR). Received various changes in the immune response in patients with ABA and COPD allow a better understanding of
the features of chronic inflammation in these diseases.

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI / WHO workshop report. The 2011 report is available on www.goldcopd.com

2. Biomarkers and surrogate endpoints: clinical research and applications. Amsterdam: Elsevier Scientific; 2000. 1–7.Clin. Pharmacol. Ther. 2001; 69: 89–95.

3. Баймаканова Г.Е, Авдеев С.Н. Значение биомаркеров при хронической обструктивной болезни легких Пульмонология № 3, 2013, стр. 105–110

4. Порядин Г.В, Салмаси Ж.М, Казимирский А.Н и др. Особенности развития иммунного ответа в процессе развития воспаления при атопии. «Клиническая патофизиология» 2002 г.№ 1.с.5–10.

5. Abramson M.J., Perret J.L., Dharmage S.C., McDonald V.M., McDonald C.F. Distinguishing adult-onset asthma from COPD: a review and a new approach.// Int. J. Chron. Obstr. Pulmon. Dis.-2014, N9 P.945–962

6. Хаитов Р.М., Игнатьева Г.А., Сидорович И.Г. Иммунология. М.: Медицина 2-е издание. — 2002 — 536 С.

7. Распопина Н.А.,. Шуганов А.Е., Палеев Ф.Н., Салмаси Ж.М,.Казимирский А.Н Роль цитотоксических лимфоцитов в воспалении у больных ХОБЛ в стадии обострения и ремиссии. Медицинский альянс. № 1 , 2014, 12–16 стр.

8. Tsoumakidou M., Tzanakis N., Kiriakou D., Chrysofakis G., Siafakas N.M. Inflammatory cell profiles and T-lymphocyte subsets in chronic obstructive pulmonary disease and severe persistent asthma.//Clin. Exp. Allergy. 2004; 34 (2):234–240

9. Culley F.J. Natural killer cells in infection and inflammation of the lung.// Immunology, 2009, 128 (2):151–163

10. Rijavec M., Volarevic S., Osolnik K., Korosec P. Natural killer T cell in pulmonary disorders. // Respir. Med., 2011,105 Suppl 1 S20–5

11. Порядин Г.В., Салмаси Ж.М. Макарков А.И. Механизмы регуляции экспрессии поверхностных структур дифференцированного лимфоцита. Иммунология-1997.-№ 3.с.4–8

12. Robertson M.J,Cameron C. et al. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell dependent signals. Nat.Immun.1996–1997;15(5):213–26

13. Bisset L.R., Lung T.L., Kaelin M., Labwig E., Dubs R.W. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy about population in Switzerland.// Euro J Haematol. — 2004 — V.72,N3, Mar, P.203–212.

14. Порядин Г.В.,Салмаси Ж.М., Казимирский А.Н Сравнительная характеристика маркеров Fas-зависимого апоптоза у больных бронхиальной астмой и ХОБЛ. Российский иммунологический журнал, 2013, т. 7, № 2–3, С. 207

15. Барышников А.Ю., Шишкин Ю.В., Иммунологические проблемы апоптоза М.: Эдиториал УРСС,2002.

16. Harnett M.Rigley K. The role of G-proteins versus protein tyrosine kinesis in the regulation of lymphocyte activation.// Immunol.Today-1992.-V.13N12-P.482–486

17. Stalder T., Hans S., Erb P. Fas antigen is the major target molecule for CD4+ T-cells-medisted cytotoxicity.//J.Immunol.-1994-V.152,#3.-P.1127–1133.